Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $110,000 of XYLEM INC. lobbying was just disclosed

None

$110,000 of XYLEM INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Monitor issues affecting water technology sector; support of HR2940 Advancing Water Reuse Act; support of S2388 Water Infrastructure Modernization Act; issues related to artificial intelligence and water reuse; Monitor development of Interior and Energy-Water Appropriations bills Support of HR2940 Advancing Water Reuse Act Issues affecting the water technology sector."

You can find more data on corporate lobbying on Quiver Quantitative.

XYL Insider Trading Activity

XYL Insider Trades

XYL insiders have traded $XYL stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $XYL stock by insiders over the last 6 months:

  • CLAUDIA S TOUSSAINT (EVP, CPSO) sold 10,421 shares for an estimated $1,590,661
  • LISA GLATCH sold 4,900 shares for an estimated $689,231
  • VICTORIA D HARKER has made 0 purchases and 2 sales selling 3,500 shares for an estimated $510,379.
  • GERI-MICHELLE MCSHANE (VP, CAO) sold 1,000 shares for an estimated $139,962

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

XYL Hedge Fund Activity

We have seen 530 institutional investors add shares of XYL stock to their portfolio, and 461 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

XYL Analyst Ratings

Wall Street analysts have issued reports on $XYL in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • UBS issued a "Buy" rating on 11/06/2025
  • Citigroup issued a "Buy" rating on 10/29/2025
  • Barclays issued a "Overweight" rating on 10/29/2025
  • Stifel issued a "Buy" rating on 10/29/2025
  • RBC Capital issued a "Outperform" rating on 10/29/2025
  • JP Morgan issued a "Overweight" rating on 05/30/2025

To track analyst ratings and price targets for XYL, check out Quiver Quantitative's $XYL forecast page.

XYL Price Targets

Multiple analysts have issued price targets for $XYL recently. We have seen 8 analysts offer price targets for $XYL in the last 6 months, with a median target of $173.5.

Here are some recent targets:

  • Damian Karas from UBS set a target price of $175.0 on 11/06/2025
  • William Grippin from Barclays set a target price of $172.0 on 10/29/2025
  • Andrew Kaplowitz from Citigroup set a target price of $182.0 on 10/29/2025
  • Nathan Jones from Stifel set a target price of $178.0 on 10/29/2025
  • Deane Dray from RBC Capital set a target price of $176.0 on 10/29/2025
  • Brett Linzey from Mizuho set a target price of $140.0 on 09/12/2025
  • Joseph Giordano from TD Cowen set a target price of $130.0 on 08/26/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles